Microba Life Sciences Limited

ASX (AUD): Microba Life Sciences Limited (MAP)

Last Price

0.09

Today's Change

+0.001 (1.12%)

Day's Change

0.087 - 0.09

Trading Volume

273,281

Overview

Market Cap

40 Million

Shares Outstanding

447 Million

Avg Volume

481,116

Avg Price (50 Days)

0.09

Avg Price (200 Days)

0.17

PE Ratio

-3.00

EPS

-0.03

Earnings Announcement

04-Mar-2026

Previous Close

0.09

Open

0.09

Day's Range

0.087 - 0.09

Year Range

0.082 - 0.325

Trading Volume

273,281

Price Change Highlight

1 Day Change

1.12%

5 Day Change

-4.26%

1 Month Change

-2.17%

3 Month Change

-25.00%

6 Month Change

-52.63%

Ytd Change

-53.85%

1 Year Change

-48.57%

3 Year Change

-54.59%

5 Year Change

-72.75%

10 Year Change

-72.75%

Max Change

-72.75%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic leads, consumer health innovations, and diagnostic biomarkers; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases. The company was incorporated in 2017 and is based in Brisbane, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment